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Lyon rat models of metabolic syndrome
Man Chun John Ma1, Santosh S Atanur2, Timothy J Aitman2 and Anne E Kwitek1,3*Abstract
Background: The metabolic syndrome (MetS), a complex disorder involving hypertension, obesity, dyslipidemia
and insulin resistance, is a major risk factor for heart disease, stroke, and diabetes. The Lyon Hypertensive (LH), Lyon
Normotensive (LN) and Lyon Low-pressure (LL) rats are inbred strains simultaneously derived from a common
outbred Sprague Dawley colony by selection for high, normal, and low blood pressure, respectively. Further studies
found that LH is a MetS susceptible strain, while LN is resistant and LL has an intermediate phenotype. Whole
genome sequencing determined that, while the strains are phenotypically divergent, they are nearly 98% similar at the
nucleotide level. Using the sequence of the three strains, we applied an approach that harnesses the distribution of
Observed Strain Differences (OSD), or nucleotide diversity, to distinguish genomic regions of identity-by-descent (IBD)
from those with divergent ancestry between the three strains. This information was then used to fine-map QTL identified
in a cross between LH and LN rats in order to identify candidate genes causing the phenotypes.
Results: We identified haplotypes that, in total, contain at least 95% of the identifiable polymorphisms between the Lyon
strains that are likely of differing ancestral origin. By intersecting the identified haplotype blocks with Quantitative Trait
Loci (QTL) previously identified in a cross between LH and LN strains, the candidate QTL regions have been narrowed by
78%. Because the genome sequence has been determined, we were further able to identify putative functional variants in
genes that are candidates for causing the QTL.
Conclusions: Whole genome sequence analysis between the LH, LN, and LL strains identified the haplotype structure
of these three strains and identified candidate genes with sequence variants predicted to affect gene function. This
approach, merged with additional integrative genetics approaches, will likely lead to novel mechanisms underlying
complex disease and provide new drug targets and therapies.
Keywords: Metabolic syndrome, Rat genetic model, Genetic mapping, Genome sequence, Nucleotide diversity, EvolutionBackground
Metabolic Syndrome (MetS) is a constellation of disorders
which include obesity, insulin resistance or hyperglycemia,
dyslipidemia and hypertension, the combination of which
have been found to significantly increase the risk for cardio-
vascular disorders and type II diabetes [1]. According to data
compiled by the National Health and Nutrition Examination
Survey in 2009, more than one-third of the U.S. population
falls into the criteria for metabolic syndrome [2], making it a
major public health issue. Diagnosis of MetS is made with
the co-occurrence of any three of the defining features [1].* Correspondence: anne-kwitek@uiowa.edu
1Department of Pharmacology, University of Iowa, Iowa City, IA, USA
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Commons Attribution License (http://creativec
reproduction in any medium, provided the orWhile the associated features often occur together and have
clear genetic contribution, the common pathways or mecha-
nisms linking them in MetS is not well understood.
Identification of the genetic contribution to complex
disease is greatly aided by comprehensive studies involving
genetic models. The Lyon inbred rat strains were derived
in the early 1970s from a single outbred Sprague–Dawley
(SD) colony for different blood pressure levels: hyperten-
sion (Lyon Hypertensive; LH/Mav), normotension (Lyon
Normotensive; LN/Mav) and hypotension (Lyon Low-
pressure; LL/Mav) [3]. While LN rats have normal blood
pressure, LL rats have late onset hypotension while LH
rats are spontaneously hypertensive by 5 weeks of age
[4,5]. Initially established as a model of hypertension, sev-
eral defining features of the metabolic syndrome (MetS)
have also been observed in LH [1,6]. These include obes-
ity, dyslipidemia with an increase in total triglycerides,. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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ratio, which suggests a susceptibility to insulin resistance
[4,6,7]. Therefore the LH rat is a MetS susceptible rat. The
study of the Lyon strains, having differing genetic suscepti-
bilities to traits defining MetS, can be used to dissect the
underlying genetic causes of the defining features of a dis-
order that carries a significant health burden [8,9].
We previously identified quantitative trait loci (QTL)
for phenotypes defining MetS in an F2 intercross be-
tween LH and LN rats, including body weight, blood
pressure, plasma lipid levels, and plasma insulin levels
[10]. While many of the traits were influenced by QTL
on different chromosomes, this study determined that
rat chromosome (RNO) 17 contains QTLs for multiple
features of MetS (body weight; blood pressure; plasma
cholesterol, triglyceride, and insulin levels). While blood
pressure and plasma lipid levels were correlated in the
F2 cross, body weight was not found to be correlated
with either of these traits [6], suggesting the QTL on
RNO17 for body weight may have been due to the co-
segregation of a passenger locus during selection rather
than the pleiotropic effect of a single MetS gene on this
chromosome.
Because the inbred strains were derived from a single
SD colony, the Lyon strains share high genetic similarity.
Phylogenetic studies consistently find the LH, LN, and
LL strains in a well-defined cluster of SD-derived inbred
rat strains [11-13]. The shared lineage between LH and LN
strains also resulted in a paucity of informative poly-
morphic markers between the strains; therefore, the QTL
intervals in our previous mapping study were large, and
generating congenic and consomic strains by marker-
assisted selection was a challenge. Consomic strains intro-
gressing the more genetically divergent BN chromosomes
13 or 17 succeeded in recapitulating some of the pheno-
types – body weight, triglycerides, and blood pressure –
that were identified in the QTL analysis [14,15]. However,
the genetic similarity between the Lyon strains presents an
opportunity to utilize haplotype mapping to fine-map the
loci, if sufficient polymorphic markers could be identified.
In 2007, the STAR Consortium released genotypes for
163 inbred rat strains, including the LH and LN strains,
from a 20,238-SNP panel [12]. As was previously deter-
mined using microsatellite markers [11], phylogenetic ana-
lyses for the rat strains using the 20 K SNP panel indicated
a close genetic relationship between the LH and LN
strains. Of the 20,238 SNPs in the panel, only 1,739
(8.59%) are polymorphic between LH and LN. Further-
more, the variants clustered into what could be considered
putative LD blocks. We assert the genetic determinants for
the LH phenotypes reside in LD blocks that differ between
the strains, due to artificial selective sweeps from the SD
progenitors. Yet, like any SNP genotyping panels, the
STAR Consortium panel, determined by an ascertainmentpanel consisting of SS/Jr, GK/Ox, SHRSP/Bbb, WKY/Bbb
and F344/Stm strains [12], is subject to the ascertainment
biases observed in SNP panels in general [16] that can im-
part large effects on many metrics of linkage disequilib-
rium [17]. Resequencing of the genomes eliminates SNP
genotyping biases and allows for more accurate LD ana-
lyses; however until recently only a few rat strains had
available genome sequence: BN/SsNHsD [18], SHR/
OlaIpcv [19], and SD.
We previously determined the single nucleotide poly-
morphism (SNP) density across the genomes of the SHR
and BN strains as a means to visualize the substantial di-
versity between the two strains [19]. When plotting the
genome-wide distribution of SNPs between the strains,
we observed a bimodal distribution with one peak in the
distribution curve having a low SNP density and the
other having a high SNP density [19]. The Observed
Strain Differences (OSD), or the density of variants be-
tween two strains across a fixed genome sequence win-
dow size, represent a local measure of polymorphic sites.
Recently we published the genome sequences of 27
different inbred rat strains including the LH, LL, and LN
strains [13]. In this study we reported data regarding
artificial selective sweeps among the rat strains, and sug-
gest that shared genetic material between strains origin-
ating from the same founder population, irrespective of
their phenotype, reflects their common ancestry. Con-
sidering LH and LN rats were generated through select-
ive breeding from a common origin, we assert the
regions with low SNP density are likely regions of shared
lineage while the regions with high density would likely
to be from different ancestral chromosomes that contain
genetic determinants of their phenotypes due to artificial
selection from the founder outbred SD rats. As reported
here, OSD analysis was performed in the Lyon rat
strains in order to fine-map the QTL, particularly on
RNO17, and identify candidate genes relating to MetS in
the LH rat by comparing sequence variation in this
strain to that of the other Lyon strains.
Results
Genome-wide Observed Strain Difference (OSD) analyses
For the OSD analyses, six comparisons were performed
in two groups. First, each of the three Lyon strains was
compared with the BN reference genome (LH/BN; LN/
BN; LL/BN). Second, all possible pairwise comparisons
between the Lyon strains (LH/LN; LH/LL; LL/LN) was
performed to identify regions of the genomes between
the strains with ancestrally distinct haplotypes derived
from the outbred SD rats.
In all comparisons (Figure 1), the OSD distribution of
the 27,199 100Kb-windows spanning the rat genome is
bimodal, as was previously reported in the comparison
between SHR and BN strains [19]. The first (left) peak in
Figure 1 Distributions of Observed Strain Difference (OSD) over 100Kb windows. OSD distribution is represented as the curve of kernel
density estimates (Y axis) against OSD (X axis). The scale of the Y-axis is square-root transformed. The Polymorphism Enrichment Thresholds (PET)
for each comparison is marked with a vertical line.
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identical by descent, with OSD values close to zero (i.e.
low SNP density). The second (right) peak in the bi-
modal distribution contains regions of the genome that
are ancestrally divergent between the two strains, having
high OSD values (i.e. high SNP density). A distinct valley
separates the two peaks; we define the OSD value at this
valley as the Polymorphism Enrichment Threshold (PET).
The average PET in the Lyon vs. BN and the pairwise
Lyon strain comparisons is 4.5 × 10−4 and 3.7 × 10−4, re-
spectively (Table 1). Regions with SNP density values
higher than the PET represent the windows within ances-
tral haplotype blocks that differ between the strains.
Comparing the SNP densities between the groups of
comparisons, distinct differences in the nature of the
distribution curves were observed (Figure 1). While all
comparisons show a bimodal distribution, the number of
windows with low SNP density (and accordingly low
OSD values) is approximately 4-fold higher in the Lyon
pairwise group than in the Lyon vs BN group. Con-
versely, the number of windows with high SNP density
(high OSD values) is over 3-fold lower in the Lyon pair-
wise groups compared to the Lyon vs BN groups. Thistrend is consistent with the fact that the Lyon strains are
evolutionarily close to each other but evolutionary dis-
tant from the BN strain [12]. It also explains the low
amount of polymorphism between the Lyon strains as
compared to the Lyon vs BN comparisons (Table 1). The
percentage of 100Kb windows with high SNP density in-
creases from an average of 14.40% in Lyon pairwise
comparisons to 66.44% in Lyon vs BN comparisons.
In order to determine haplotype blocks between the
strains being compared, adjacent windows with SNP
density exceeding the PET were concatenated. There
were 3-fold more divergent haplotype blocks in the Lyon
vs BN comparisons compared to the Lyon pairwise com-
parisons, with an average of 1,408 in Lyon vs BN groups
compared to an average of 441 in Lyon pairwise groups
(Table 1). Furthermore, the divergent haplotypes in the
Lyon strains comparisons were on average less than 0.9
Mb in length, whereas the Lyon vs BN haplotypes were
nearly 50% longer, with an average of over 1.3 Mb. To-
gether, these data are consistent with the breeding his-
tory of the Lyon rat strains.
The haplotype blocks were then aligned to the refer-
ence BN sequence to determine their distribution in the
Table 1 Summary Statistics for OSD analyses for six strain comparisons
Comparison PET # Windows>
PET
% Windows>
PET
# divergent
haplotype
blocks
Average
block
length
SD block
length
Average
OSD first
peak
Average OSD
second
peak
# SNPs in
comparison
# SNPs in
haplotype
blocks
% SNPs in
haplotype
blocks
Lyon vs BN
LH/BN 4.50x10−4 18,242 67.07 1,431 1,431,996 1,506,679 5.44x10−5 1.69x10−3 3,127,650 3,078,898 98.44
LL/BN 4.52x10−4 17,989 66.14 1,396 1,287,865 1,565,760 5.10x10−5 1.69x10−3 3,094,251 3,047,301 98.48
LN/BN 4.57x10−4 17,982 66.11 1,398 1,285,500 1,493,916 5.05x10−5 1.69x10−3 3,082,757 3,036,234 98.49
Average 4.53x10−4 18,071 66.44 1,408 1,335,120 1,522,118 5.20x10−5 1.69x10−3 3,101,553 3,054,144 98.47
Lyon pairwise
LH/LN 3.69x10−4 4,202 15.45 477 880,419 960,896 5.28x10−6 1.50x10−3 643,234 630,814 98.07
LH/LL 3.84x10−4 4,041 14.86 485 828,584 851,988 5.68x10−6 1.56x10−3 643,233 630,878 98.08
LL/LN 3.44x10−4 3,510 12.90 360 968,953 1,048,667 3.74x10−6 1.49x10−3 532,429 531,904 99.90
Average 3.66x10−4 3,918 14.40 441 892,652 953,850 4.90x10−6 1.52x10−3 606,299 597,865 98.68
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distribution of haplotype blocks across the genome was
highly variable. For example, in the LH/LN compari-
son (Figure 2, Additional file 1: Table S1), approxima-
tely 15.5% of the genome contains divergent haplotypeFigure 2 Patterns of OSD Distribution over 100Kb across the genome inblocks. In comparison, nearly 31% of chromosomes 2, 10
and 12 are comprised of divergent haplotype blocks,
while only approximately 5% of chromosomes 7, 14 and
20 encompass divergent haplotype blocks. The latter
three chromosomes also have long stretches of 50 Mb orthe LH/LN comparison. The scale of the Y-axis is square-root transformed.
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is, regions that are shared ancestrally.
Because of the phenotype-driven selection of the Lyon
strains from a common SD ancestor, it is likely that di-
vergent haplotypes arising from artificial selective sweeps
will contain variants causing the phenotypic differences
between the strains. In order to fine-map QTL intervals
for MetS traits previously mapped in a cross between
LH and LN rats, we aligned both the haplotype blocksa
b
Figure 3 The overlap between previously reported QTLs and the dive
comparison; (B): A focus on the chromosomes 1, 2, 3, 5, 7, 10, 13 and 17 th
red marks QTL intervals identified by Bilusic et al. and blue marks intervals
Idiographica [21].and QTL onto the rat genome and determined where
the two overlap [10]. Using the genomic coordinates
provided by the Rat Genome Database [20], the QTL in-
tervals cover a total of ~860 Mb bp, or 33% of the entire
rat genome (Figure 3a). However, only 21% of these in-
tervals (183 Mb) contain haplotypes differing between
LH and LN strains. Therefore, these studies allow for in
silico fine-mapping of QTL intervals, narrowing them by
nearly 80%, and particularly on the chromosomes withrgent haplotype blocks between LH and LN. (A): Genome-wide
at contains at least one QTL identified by Bilusic et al. In both figures
containing divergent haplotype blocks. Idiograms were drawn using
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7 and 17 (Figure 3b, Additional file 1: Table S1).
Patterns of Haplotype Blocks on RNO17
Despite strong evidence that RNO17 has genetic deter-
minants contributing to multiple symptoms of MetS, the
paucity of markers polymorphic between LH and LN
presents a particular challenge to fine-map the genetic
loci on this chromosome. Therefore, here we applied the
OSD-based approach to RNO17 to fine-map the genetic
loci identified in the cross between LH and LN rats
(Figure 4). When comparing the Lyon vs. BN groups to
the Lyon pairwise groups, it is clear that the majority of
the chromosome is divergent in the Lyon vs. BN com-
parison with only small haplotype blocks in common,
while the vast majority of RNO17 is conserved among
the Lyon strains. We identified 14 haplotype blocks on
RNO17 that differ between the LH and LN strains
(Table 2). The span of these blocks cover 7.5 Mb, or
7.7% of the chromosome, and contain 11,852 of 12,175
SNPs (97.3%) between LH and LN rats on this chromo-
some identified by resequencing (Table 2, Additional file
1: Table S1). The percentage of RNO17 representing an-
cestrally different haplotype blocks are half of the genomic
average of 15.4%, further demonstrating the similarity be-
tween LH and LN strains on this chromosome.
The LH and LN strains have previously undergone
genome-wide SNP genotyping by the STAR consortium
[12]. From these genotyping results we deduced a list of pu-
tative haplotype blocks on RNO17 and compared them to
the OSD-based results (Table 2). The haplotype blocks
identified by both approaches are largely similar, with both
identifying blocks at 29–30 Mb, 39 Mb, 42–43 Mb, 62–65
Mb, 69–70 Mb and 91 Mb. However, the present approach
identified three novel putative haplotype regions at 30.7-
30.9 Mb, 53.4-53.8 Mb, and 83.6-83.9 Mb. In addition,
while both approaches identified a haplotype block ending
at approximately 43.1 Mb, the start site of the block as
identified by OSD analysis extends the 5′end by approxi-
mately 500 Kb compared to the one identified by SNP
genotyping (41.7 vs 42.2 Mb, respectively), making the
block about 47% longer. On the other hand, SNP genotyp-
ing identified a 1.6 Mb haplotype block spanning 38.2-39.8
Mb, while OSD analysis refined this block to 0.2 Mb (39.4-Figure 4 Divergent haplotype blocks of different comparisons on RNO
bottom the LH/LN haplotype blocks identified by SNP genotyping was add39.6 Mb), which can largely be attributed by the full map
resolution provided by resequencing. Overlaying the haplo-
types with the mapped QTL implicate blocks 1–12 as most
likely to contain causal genes for the mapped traits.
Genes and SNVs located in Haplotype Blocks
Using the OSD analysis to identify ancestrally different
haplotypes allows us to focus initial efforts identifying
causal genes for the QTL in the LH rat. The 477 haplo-
types divergent between LH and LN contain 3,687
protein-coding genes; 1,789 of these genes fall within one
or more of the previously identified QTLs [10]. The rese-
quencing of the Lyon strains identified 643,234 SNPs and
327,067 indels across the genome in the LH/LN compari-
son, of which 630,814 and 235,414 are located in the
haplotype blocks [13]. Genome-wide, there are 2,391 SNPs
and 542 indels in the LH/LN comparison that Variant Ef-
fect Predictor (VEP) [22] classified as causing non-
synonymous coding, frameshift, splice site changes, and/
or stop codon gain/loss. Nearly all of these are located in
the haplotype blocks, including 2,083 SNVs and 383 indels
in 1,316 genes. Overlaying these SNVs and indels with
QTL regions identified 416 genes with putative functional
variation between the LH and LN strains.
On chromosome 17, there are 27 protein-coding genes
located within the haplotype blocks differing between LH
and LN strains (Table 3). All except 2 of these genes fell
within one or more of the previously reported QTLs asso-
ciated with LH phenotypes (Figure 3b) [10]. We have
identified 24 SNVs and 7 indels in 15 genes on RNO17
classified as affecting protein sequence, or splice sites, by
VEP (Table 3). Each of these variants fell within one of the
haplotype blocks differing between LH and LN strains. Of
the 31 variants, 18 variants in 11 genes were the minor al-
lele in the LH rat, and were colocalized with MetS QTL.
There were three genes (RGD1563300, Prl5a2, and
Prl4a1) with LH variants affecting splice sites and three
genes (Prl4a1, ENSRNOG00000012418, and LOC364753)
with variants that were classified as “probably damaging”
or “possibly damaging” by PolyPhen 2 version 2.2.2 [23].
To interrogate the SNVs’ possible roles in MetS traits,
Fisher’s exact test was performed to test whether the LH
allele SNVs listed in Table 3 are significantly enriched
among the sequenced rat strains [13] that have one or17. From top: LH/BN, LL/BN, LN/BN, LH/LL, LH/LN and LL/LN. At the
ed as reference.
Table 2 Divergent haplotype blocks between LH and LN
strains identified by OSD analysis and SNP genotyping data
Haplotype blocks
OSD analysis
Haplotype blocks
STAR genotyping
Block
number
Start
(mb)
End
(mb)
Length
(mb)
Start
(mb)
End
(mb)
1 29.7 30.0 0.3 29.7 30.2
2 30.1 30.3 0.2
3 30.7 30.9 0.2 novel
4 39.4 39.6 0.2 38.2 39.8
5 41.7 43.1 1.4 42.2 43.2
6 43.2 43.4 0.2
7 53.4 53.8 0.4 novel
8 62.2 63.2 1.0 62.3 65.8
9 63.4 64.9 1.5
10 65 65.9 0.9
11 69.7 69.9 0.2 69.7 70.8
12 70.4 70.8 0.4
13 83.6 83.9 0.3 novel
14 90.8 91.1 0.3 90.8 90.9
All genome position coordinates are based on the rn4 assembly.
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hypertension. One variant in LOC364753 (17:
G65,701,876 T) showed significant enrichment at p <
0.05; it was found to be enriched (p = 0.01) among the
hypertensive LH, SS and SHR strains.
Variant confirmation
To verify the existence of SNVs within the haplotype
blocks on RNO17, we performed Sanger sequencing of 6
amplicons containing 10 of the variants listed in Table 3
(Additional file 2: Table S2). These six amplicons gener-
ated a total of 3,848 base pairs of sequence. All 10 vari-
ants were validated by Sanger sequencing, with the LH
and LN allele identical to genome resequencing results.
Furthermore, we were able to verify 20 of the 23 SNVs
that were annotated in the genome sequence and identi-
fied an additional SNV that was not previously anno-
tated. These results reflect the high quality of the
genome sequence of the strains.
Discussion
In this paper we report a simple technique to distinguish
genomic regions of identity-by-descent (IBD) from those
with different ancestry using genome resequencing re-
sults from a group of rat strains that shares a common
origin but were selectively inbred for differing pheno-
types. Genetic studies in phenotype-selected inbred ro-
dent strains derived from a common ancestor are a
common strategy to map loci for many complex disor-
ders, ranging from anxiety [24,25] to hypertension [26].The similar genetic background strains minimizes the
heterogeneity outside of the regions phenotypically se-
lected, making identity-by-descent (IBD) mapping a
means to eliminate disease-causing regions of the gen-
ome. However, their similar genetic backgrounds also
present problems to the investigator, as their similarities
result in a paucity of polymorphic markers available to
attain an acceptable marker resolution for mapping.
Using next-generation sequencing (NGS) techniques to
resequence the genomes of these strains can resolve this
problem as NGS, by definition, samples all bases, and
hence should be able to identify all polymorphisms be-
tween strains, allowing high-resolution IBD mapping. In
the case of the Lyon strains, which share similar SD ances-
tors, we distinguished ancestral haplotypes that have been
fixed in the course of selective inbreeding from the ran-
dom mutations that were fixed after the division of the
strains in order to fine-map QTL for traits defining MetS.
The results presented here confirm previous data re-
garding the genomes of different laboratory mouse
strains, which also observed bimodal distributions of
SNP densities in non-overlapping windows across the
genome [27,28]. By resequencing a selection of putative
SNPs from each peak, Wade et al. found that SNPs iden-
tified in the low SNP density regions are likely to be
spurious, while those identified on the high SNP density
regions are likely to be validated [27]. Furthermore, by
comparing the distribution of nucleotide diversity (π)
[29] among synonymous SNPs in cDNA transcripts in
laboratory mouse strains, wild-derived mouse strains
(control for high diversity), as well as a rat strain from a
single founder (control for low diversity), Reuveni and
colleagues assert that the bimodal distribution of π in la-
boratory mice is contributed by two groups of SNPs:
intra-subspecific SNPs and inter-subspecific SNPs, rep-
resented by the low π and high π peaks respectively [30].
While that paper mainly discusses mouse subspecies, we
expect the implication can also be extrapolated to strain
differences. In this case, SNPs that were represented by
the low- π peak (or the low-OSD peak in this case) are
likely to be SNPs that arise after the separation of the
strains, while SNPs that were represented by the high- π
peak, or high-OSD peak, represents SNPs that originate
from the genetic differences between the founder strains.
The observed bimodal distribution of SNP density has
previously been reported by Wang et al. in a similar
comparison between the indica and japonica subspecies
of rice, using microarray genotyping and a window size of
200 kB [31]. Furthermore, whole-genome resequencing
between individual strains within the indica subspecies
showed similar results as lower-density SNP typing [32].
The evolutionary histories of rice the Lyon strains are
different. However, artificial selection from a single ori-
gin was put forward by the authors as an explanation for
Table 3 Genes and non-synonymous variations in LH vs LN haplotype blocks on RNO17
Gene name Gene start (bp) Gene end (bp) Description Nucleotide Substitution AA Substitution Variant
strain
Classification
Block 1 (29.7-30 Mb)
Tmem14c 29,701,923 29,708,044 Transmembrane protein 14C
Pak1ip2 29,710,407 29,721,477 PAK1 interacting protein 1
RGD1562963 29,733,271 29,746,769 Similar to chromosome 6 open reading
frame 52
G29,733,378A V36I LH Benign
G29,741,903A R135H Benign
G29,741,915A C139Y Benign
Gcnt2 29,767,388 29,872,873 N-acetyllactosaminide beta-1,6-N-
acetylglucosaminyl-transferase
C29,872,483 T A131T LN Benign
Block 2 (30.1-30. Mb)
LOC100362620 30,267,398 30,267,637 CDC28 protein kinase regulatory subunit 2 G30,267,440A E15K LN Benign
T30,267,495C L33P Benign
G30,267,526C W43C Benign
G30,267,578 T E61* N/A
Block 5 (41.7-43.1 Mb)
RGD1563300 42,228,845 42,229,431 Similar to 60S ribosomal protein L29 (P23) g.42299020_42299027delACTCCGGT LH Essential splice site
g.42299028_42299029insCACAAAGATA X29fs LN Frameshift
Prl5a2 42,984,939 42,991,275 Prolactin family 5, subfamily a, member 2 G42,989,474A P14L LH Benign
A42,986,191 T LH Splice site
Block 6 (43.2-43.4 Mb)
Prl5a1 43,119,152 43,126,570 Prolactin-5A1
Prl4a1 43,276,214 43,284,152 Prolactin-4A1 G43,278,266 T T141N LH Splice site, possibly
damaging
Block 7 (53.4-53.8 Mb)
Stard3nl 53,402,078 53,436,081 MLN64 N-terminal domain homolog
ENSRNOG00000027571 53,441,303 53,484,317 Uncharacterized protein G53,441,394A T161I /T313I* LH Benign
C53,463,467 T V124I LH
g.53483901_53483997del 73_105del LN Frameshift
ENSRNOG00000012418 53,496,423 53,528,130 Uncharacterized protein G53,527,707 T P81T LH Possibly damaging
T53,527,779A T57S LH Benign
G53,528,005A P15S LH Probably damaging
G53,528,025 T A8D LH Possibly damaging
Amph 53,558,804 53,802,936 Amphiphysin C53,558,811A R632L LH Benign
g.53641892_53641893delCT c.152_153delAG LN
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Table 3 Genes and non-synonymous variations in LH vs LN haplotype blocks on RNO17 (Continued)
ENSRNOG00000038737 53,773,036 53,773,733 Uncharacterized protein
Block 8 (62.2-63.2 Mb)
Bambi 62,654,080 62,658,885 BMP and activin membrane-bound
inhibitor homolog
RGD1564129 62,684,244 62,686,747 Uncharacterized protein
Cul2 62,701,289 62,741,344 Cullin-2
Crem 62,770,633 62,837,668 cAMP-responsive element modulator
Epc1 63,041,415 63,104,046 Enhancer of polycomb homolog 1 A63,102,600 T L55H LH Benign
Block 9 (63.4-64.9 Mb)
Rab18 63,497,924 63,529,227 Ras-related protein Rab-18 A63,528,108 T S193C LN Benign
Mkx 63,631,426 63,710,099 Mohawk Homeobox G63,631,814A P301L LH Benign
Armc4 63,931,393 63,955,410 Armadillo repeat containing 4
Mpp7 63,992,387 64,282,554 MAGUK p55 subfamily member 7
Wac 64,531,772 64,587,027 WW domain containing adaptor
with coiled-coil
T64,570,567G C200G LH Benign
Block 10 (65.0-65.9 Mb)
LOC364753 65,681,793 65,702,382 similar to NSFL1 (p97) cofactor (p47) G65,701,876 T G80C LH Possibly damaging
Block 13 (83.6-83.9 Mb)
ENSRNOG00000031981 83,837,499 83,861,361 Uncharacterized protein C83,860,804 T P40S LH Benign
g.83861107_83861122delATCCCTGCATCCCTGC I141fs LN Frameshift
g.83861220_83861227delCCCTGCAT T178fs LH Frameshift
g.83837957_83837958insA LH Splice site
Block 14 (90.8-91.1 Mb)
Plxdc2 90,572,391 90,982,073 Plexin domain-containing protein 2
Variants in bold were validated by Sanger sequencing.
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http://www.biomedcentral.com/1471-2164/15/197the bimodal distribution of SNP density. Since the Lyon
strains were in fact artificially selected from a single ori-
gin based on their blood pressure, we consider the au-
thors’ conclusion about the relationship between the
distribution of SNP densities and phenotype in rice can
be applied to the Lyon rats. Specifically, the non-IBD re-
gions between LH and LN contain genetic determinants
for the divergence between LH and LN phenotypes. This
approach has also been used among mammals, to iden-
tify genomic regions that underlie the domestication of
dogs using whole-genome sequence [33].
A caveat to our approach is the assumption that the
phenotype differences between the Lyon rat strains are
due to phenotype-driven selection of ancestrally different
loci. While we cannot formally rule out that random mu-
tation after divergence of the strains does have some
phenotypic outcome, given the multigenic nature of the
traits, we assert this approach will identify at least a subset
of the disease-causing variants. In addition, we cannot
confirm the method described in this paper is able to iden-
tify all divergent haplotype blocks between two similar
strains, particularly in genome regions lacking adequate
coverage. However this approach is appropriate to priori-
tize genetic loci that may contain genetic determinants for
the phenotype in question which can be verified in vivo by
using consomic and/or congenic strains [34].
In the Lyon pairwise comparisons, no more than 15%
of the 100 Kb blocks on the genome have been identified
as divergent haplotype blocks, yet these blocks contain
more than 97% of all identifiable SNPs in the compari-
sons (Table 1). Specifically, in the LH/LN comparison,
divergent haplotype blocks encompass 420.0 Mb of the
rat genome. QTL intervals mapped in a cross between
the two strains encompass 827 Mb of the genome. Com-
bining the QTL and haplotype mapping narrowed the
loci by nearly 80% to 183 Mb [10], allowing a more re-
fined focus for gene discovery.
As mentioned previously, multiple QTL for MetS
traits were mapped to RNO17 in an LH × LN F2 inter-
cross [10]. However, the QTL intervals span nearly the
entire chromosome due to the relative low density of the
genetic map. The approach reported here allowed for in
silico fine-mapping of the QTL by narrowing the pos-
sible candidate regions and thus reducing the number of
candidate genes to 25. Of these, 11 are protein-altering
variants in the LH rat, 5 of which are predicted to nega-
tively impact function. Two prolactin genes (Prl5a2 and
Prl4a1) have variants predicted to be damaging in the
LH rat. Interestingly, low serum prolactin levels have
been reported to be associated with MetS in humans,
both women and men [35,36]. Furthermore, plasma pro-
lactin levels were found to be significantly decreased in
the GK rat, an inbred model of type 2 diabetes. Interest-
ingly in a cross between GK and BN rats, plasmaprolactin levels were linked rat chromosome 17 in male
rats [37]. Furthermore, the GK and LH rats share the same
haplotypes for these genes, as do BN and LN strains.
However, at this locus, the GK allele was actually associ-
ated with higher plasma prolactin levels. Therefore the im-
pact of the variants in these prolactin genes is unclear.
The remaining three genes with predicted functional
variants in the LH rat either had no known function
(RGD1563300 and Loc364753) or no previously reported
relationship with MetS, such as ENSRNOG00000012418,
which has sequence similarity with T cell receptor
gamma variable genes (TRGV).
Other genes in the haplotype blocks may not have non-
synonymous variants characterized as ‘benign’ by predic-
tion software, but have been associated with symptoms of
MetS in previous research. Haplotype block 1 contains
RGD1562963, a rat ortholog of human C6ORF52. The bo-
vine ortholog of RGD1562963 falls within bovine QTL223,
involving in beef marbling, i.e. the deposition of fat in bo-
vine muscles [38,39]. This gene contains three non-
synonymous SNPs in LH, albeit the prediction software
categorized as the variants as being “benign.” Amphiphysin
(Amph) is a gene in haplotype block 7 with a nonsynon-
ymous mutation causing a R632L amino acid change that
is categorized as “benign” by PolyPhen2 in the LH rat.
While loss of function mutations in this gene are known
to cause Stiff Person Syndrome [40], a SNP in Amph is
also associated with sagittal diameter (a measure of central
obesity) in the Framingham Heart Study 100 K dataset
[41]. LH rats also have a nonsynonymous (C200G) muta-
tion in Wac, a gene that may be essential in Golgi biosyn-
thesis [42]. Interestingly, the variant in Wac is unique to
LH and SS strains and could thus underlie their shared
phenotypes of hypertension [13].
Finally, other genes in the haplotypes underlying the
MetS QTL on LH chromosome 17, have no identified
coding variants, but have notable function related to MetS.
Blocks 8 to 10, separated by two 100Kb windows, includes
several genes of note. Bambi is a protein that modifies
TGF-beta signals by acting as a pseudo-receptor [43].
Knocking out Bambi in the mouse results in a weight de-
crease in females [44] and an increase in arterial wall neo-
vascularization [45]. Cul2 is part of the VHL tumor
suppression complex that ubiquitinates HIF1α [46]; the
disruption of HIF1α has been found to improve the insulin
sensitivity and decrease adiposity in mice [47]. Also, muta-
tions in another member of the cullin family, CUL3, have
been found to cause some Mendelian forms of hyperten-
sion [48]. Crem is an inducible CREB repressor whose
down-regulation has been shown to contribute to insulin
resistance in obese human and mice through the resulting
increase in CREB expression [49], and mouse knockout
models show protection against cardiopathy and left
ventricular dysfunction, especially after exposure to
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been determined to cause at least one case of Maturity-
onset diabetes of the young (MODY) [52] and has been
associated with left ventricular hypertrophy, BMI and inci-
dence of cardiovascular diseases in the Framingham study
[53-55]. Of note, this region falls in the peak of linkage for
blood pressure and plasma lipid QTL previously mapped
in the LH × LN intercross [10]. While these genes are in-
teresting candidate genes, further studies are required, for
example in congenic strains, to establish their roles in
MetS.
We could only identify one non-synonymous SNV on
the haplotype blocks of RNO17 that has the LH allele
overrepresented among strains having MetS symptoms, a
variant in LOC364753 (17:G65,701,876 T) that showed
significant enrichment among the strains LH, SS and SHR.
Interestingly, this is an LH variant predicted to be ‘possibly
damaging.’ However, the variant T allele is actually con-
served across vertebrates; therefore it is not likely to play a
causal role in our phenotypes. Furthermore, many of these
variants are rare, which may decrease the power of the
Fisher’s exact test. For example, two of the non-
synonymous variations in RGD1562963 are only observed
in LH and SR/Jr among the sequenced strains (both de-
rived from SD rats), and the variation causing non-
synonymous mutations in Wac are only observed in LH
and SS rats. While the coselection of genes common to
hypertension is obvious in the LH and SS strains in the
case of Wac, the shared alleles in RGD1562963 between
LH and SR strains in relation to MetS is less obvious.
While SR rats are commonly studied as a normotensive
model of the salt-sensitive SS/Jr, they actually have ele-
vated body weights compared to SS rats [56,57]. There-
fore, while performing association studies in inbred strains
may identify some genes for MetS, the heterogeneity of
the phenotypes and their underlying causes complicate
gene discovery. In fact, our analyses across multiple inbred
rat strains that are models of hypertension, obesity, and
dyslipidemia found no genes in common between all dis-
ease strains [13]. Furthermore, because the traits defining
MetS are multigenic traits in themselves, some risk alleles
may be present in ‘normal’ strains but are insufficient to
independently influence the phenotype. Therefore it is im-
portant to have genetic data from QTL mapping studies
or congenic strains to confirm the in silico findings.
Conclusions
We utilized the ancestral history of the selective inbreed-
ing in the Lyon rat stains to identify LD blocks likely to
harbor causal genes by analyzing the OSD distribution
arising from the genome resequencing and overlaying
them with QTL. Using this approach we have been able to
identify a group of genes on RNO17 that may contribute
to the traits underlying MetS in the LH rat strain.The resequencing of several inbred rat strains includ-
ing the Lyon strains provides a remarkable resource for
identifying genes causing some of the most common hu-
man diseases, such as metabolic syndrome and cardio-
vascular disease. The sequence is the final component to
round out integrative genetic approaches to identify
novel MetS genes and we anticipate this resource will re-
sult in the identification of many novel mechanisms of
and therapies for one of the most common diseases of
the 21st century.
Methods
Genome resequencing
The genome sequence of the LH, LN, and LL rats was
performed previously as described [13]. All animal pro-
tocols were reviewed and approved by the IACUC at the
University of Iowa. Briefly, DNA was extracted from the
spleens of two individuals each from LH (LH/MavRrr-
cAek), LL (LL/MavRrrcAek) and LN (LN/MavRrrcAek)
strains, followed by 100 bp paired-end sequencing of
300–600 bp fragments on an Illumina Hiseq 2000 plat-
form as previously described [13]. Reads were then
aligned to the RGSC-3.4 rat reference genome [18] with
the Burrows-Wheeler Aligner version 0.5.8c [58]. The
Genome Analysis Toolkit version 1.0.6001 [59,60] was
then used to discover and genotype genomic variations.
Variants were called from reads mapped with mapping
quality greater than 10 and bases with base quality
greater or equal to 17, with the variant scores thereafter
recalibrated and filtered using GATK’s GMM model
[60]. Sequencing gaps were identified as regions of zero
coverage from the output of BEDTools’s [61] genomecov
function (Additional file 3: Table S3).
OSD analysis
Observed Strain Differences (OSD) of non-overlapping
100-kb windows across the genome were calculated as
previously described [19]. OSD was defined as the num-
ber of identified SNVs between the strains (where each
strain’s genotype is homozygous) within a 100 kb win-
dow divided by the number of nucleotides in that win-
dow that have a definitive sequence call in all the strains
being compared. For all comparisons, only positions that
have passed quality control and are homozygous across
all strains within the comparison were used in OSD
calculation.
The distribution density of OSD amongst all windows
across the genome were first smoothed by binned kernel
density estimate [62] as implemented by the R [63] pack-
age KernSmooth with default parameters. This means esti-
mating the kernel density on 401 equally spaced points
with a Gaussian kernel and with bandwidth estimated by
Wand and Jones’ oversmoothed kernel selector. From the
kernel smoothing results, a Polymorphism Enrichment
Ma et al. BMC Genomics 2014, 15:197 Page 12 of 14
http://www.biomedcentral.com/1471-2164/15/197Threshold (PET) was determined, defined as the OSD
value which is located in the local OSD minimum after
the first local OSD maximum. Putative blocks of LD were
generated by identifying and merging contiguous 100 kb
windows with OSD values greater or equal to PET. These
blocks represent haplotypes that differ between the strains
being compared.
Downstream analyses
Genes that are located within the haplotype blocks were
identified using Ensembl version 69 [64] gene annota-
tions as provided by Ensembl BioMart [65] in the Rn4
assembly. The effects of the identified SNVs and indels
were predicted by Ensembl’s Variant Effect Predictor
(VEP) [22] based on Ensembl version 69 data and using
Ensembl consequence terms. For the purpose of this
paper, non-synonymous variations are defined as varia-
tions containing the term NON_SYNONYMOUS_COD-
ING as the predicted consequence. Similarly, splice sites
variants are defined by terms SPLICE_SITE and ESSEN-
TIAL_SPLICE_SITE, frameshift variants by the term
FRAMESHIFT_CODING, and stop-gained variation by
the term STOP_GAINED from the VEP output. Poly-
Phen version 2.2.2 [23] was used to predict the effects of
SNPs identified as nonsynonymous by VEP, based on
UniProt 2012_09 data [66].
The genotypes of SNVs located within the LH/LN
haplotype blocks on RNO17 that have been annotated to
cause non-synonymous mutations or splice-site mutations
among the rat strains sequenced by Atanur et al. [13] were
obtained from Variant Visualizer within the Rat Genome
Database [20]. Potential enrichment of the LH allele
among the obese strains (LH, SBH, SS, SHR, LL and
LEW), dyslipidemic strains (LH, SS and SHR) and hyper-
tensive strains (LH, FHH, MHS, SBH, SHR, SHRSP and
SS) against the other strains were statistically tested using
two-tailed Fisher’s exact test. In this analysis all substrains
of BN were not used as they were considered identical to
the reference sequence. In addition, the strain BBDP/Rhw
was also not used out of concern that the Type I diabetes
phenotype may be confounding.
SNP genotyping-based haplotype blocks between LH
and LN strains in RNO17 were identified by visual in-
spection for contiguous regions of polymorphism from
the STAR SNP genotype panel [12]; the haplotype blocks
are defined to be the regions between the flanking
monomorphic SNPs surrounding the regions of poly-
morphic SNPs.
Variant confirmation
Seven non-synonymous variants on the haplotype blocks
on RNO17 listed on Table 3 were confirmed by Sanger
sequencing (Additional file 2: Table S2). Primers for
these amplicons were designed by Primer-BLAST [67] usingthe region 1 Kb upstream and downstream of the variation
as template, with M13 sequence (5′-TGT AAA ACG ACG
GCC AGT-3′) tagged at the 5′ ends of the forward primer
sequences and another M13 sequence (5′-GTG TGG AAT
TGT GAG CGG -3′) tagged to the 5′ ends of the reverse
primer sequences. Sequence was based on the rn4 assembly,
with the exception of one amplicon. Because the flanking re-
gion downstream of the variation at 17:43,278,266 contained
a large stretch of gaps in the rn4 assembly, the sequencing
primer set for this variation was designed using coordinating
location in the rn5 assembly (17:40,575,021).
PCR amplification was performed and products were
purified by gel electrophoresis and then sequenced bidi-
rectionally using the M13 primers listed above using ABI
3730xl sequencer with BigDye version 3.1 chemistry (Life
Technologies). Sequence traces were aligned to the genome
using SeqMan version 9.1.0 (DNASTAR Inc., Madison,
WI, USA). SNVs were validated if both strains had se-
quence passing QC and base-calling was unambiguous.
Data deposition and availability of supporting data
All sequence data was deposited in the EBI Sequence Read
Archive with accession number ERP002160 (http://www.
ebi.ac.uk/ena/data/view/ERP002160) as reported previ-
ously [13]. Sequence variants are available at the Rat Gen-
ome Database (RGD; http://rgd.mcw.edu/).
Additional files
Additional file 1: Table S1. Haplotype blocks identified between LH.
and LN strains.
Additional file 2: Table S2. Sanger sequence validation of selected
variants.
Additional file 3: Table S3. Sequence coverage in haplotype blocks.
Competing interests
The authors declare they have no competing interests.
Authors’ contributions
MCJM performed all aspects of the OSD and downstream analyses and
drafted the manuscript. SSA and TJA were responsible for the genome
sequencing and identification of sequence variants. AEK oversaw the study,
participated in its design and coordination and participated in the writing
and editing of the manuscript. All authors read and approved the final
manuscript.
Acknowledgements
We thank Janette Pettus for her helpful comments on this manuscript.
This research was funded by NIH grants 5R01HL089895 and 5R21DK089417.
Author details
1Department of Pharmacology, University of Iowa, Iowa City, IA, USA.
2Physiological Genomic and Medicine group, MRC Clinical Sciences Centre,
Imperial College London, Hammersmith Campus, London, UK. 3Iowa Institute
of Human Genetics, Department of Pharmacology, Internal Medicine,
Molecular Physiology & Biophysics, University of Iowa, 3111B MERF, 375
Newton Rd, 52242 Iowa City, IA, USA.
Received: 25 August 2013 Accepted: 1 March 2014
Published: 14 March 2014
Ma et al. BMC Genomics 2014, 15:197 Page 13 of 14
http://www.biomedcentral.com/1471-2164/15/197References
1. Alberti KGMM, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA,
Fruchart J-C, James WPT, Loria CM, Smith SC: Harmonizing the Metabolic
Syndrome. Circulation 2009, 120:1640–1645.
2. Ervin RB: Prevalence of metabolic syndrome among adults 20 years of
age and over, by sex, age, race and ethnicity, and body mass index:
United States, 2003–2006. Natl Health Stat Report 2009, 2009:1–7.
3. Dupont J, Dupont JC, Froment A, Milon H, Vincent M: Selection of three
strains of rats with spontaneously different levels of blood pressure.
Biomedicine 1973, 19:36–41.
4. Sassolas A, Vincent M, Benzoni D, Sassard J: Plasma Lipids in Genetically
Hypertensive Rats of the Lyon Strain. J Cardiovasc Pharmacol 1981,
3:1008–1014.
5. Su DF, Cerutti C, Barres C, Vincent M, Sassard J: Blood pressure and
baroreflex sensitivity in conscious hypertensive rats of Lyon strain.
Am J Physiol 1986, 251:H1111–1117.
6. Vincent M, Boussairi EH, Cartier R, Lo M, Sassolas A, Cerutti C, Barres C,
Gustin MP, Cuisinaud G, Samani NJ, Lathrop GM, Sassard J: High blood
pressure and metabolic disorders are associated in the Lyon
hypertensive rat. J Hypertens 1993, 11:1179–1185.
7. Vincent M, Cartier R, Privat P, Benzoni D, Samani NJ, Sassard J: Major
cardiovascular risk factors in Lyon hypertensive rats. A correlation
analysis in a segregating population. J Hypertens 1996, 14:469–474.
8. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM:
Prevalence of overweight and obesity in the United States, 1999–2004.
Jama 2006, 295:1549–1555.
9. Thom T, Haase N, Rosamond W, Howard VJ, Rumsfeld J, Manolio T, Zheng
ZJ, Flegal K, O'Donnell C, Kittner S, Lloyd-Jones D, Goff DC Jr, Hong Y,
Adams R, Friday G, Furie K, Gorelick P, Kissela B, Marler J, Meigs J, Roger V,
Sidney S, Sorlie P, Steinberger J, Wasserthiel-Smoller S, Wilson M, Wolf P:
Heart disease and stroke statistics–2006 update: a report from the
American Heart Association Statistics Committee and Stroke Statistics
Subcommittee. Circulation 2006, 113:e85–151.
10. Bilusic M, Bataillard A, Tschannen MR, Gao L, Barreto NE, Vincent M, Wang T,
Jacob HJ, Sassard J, Kwitek AE: Mapping the genetic determinants of
hypertension, metabolic diseases, and related phenotypes in the lyon
hypertensive rat. Hypertension 2004, 44:695–701.
11. Thomas MA, Chen C-F, Jensen-Seaman MI, Tonellato PJ, Twigger SN:
Phylogenetics of rat inbred strains. Mamm Genome 2003, 14:61–64.
12. Saar K, Beck A, Bihoreau MT, Birney E, Brocklebank D, Chen Y, Cuppen E,
Demonchy S, Dopazo J, Flicek P, Foglio M, Fujiyama A, Gut IG, Gauguier D,
Guigo R, Guryev V, Heinig M, Hummel O, Jahn N, Klages S, Kren V, Kube M,
Kuhl H, Kuramoto T, Kuroki Y, Lechner D, Lee YA, Lopez-Bigas N, Lathrop
GM, Mashimo T, et al: SNP and haplotype mapping for genetic analysis in
the rat. Nat Genet 2008, 40:560–566.
13. Atanur SS, Diaz AG, Maratou K, Sarkis A, Rotival M, Game L, Tschannen MR,
Kaisaki PJ, Otto GW, Ma MC, Keane TM, Hummel O, Saar K, Chen W, Guryev
V, Gopalakrishnan K, Garrett MR, Joe B, Citterio L, Bianchi G, McBride M,
Dominiczak A, Adams DJ, Serikawa T, Flicek P, Cuppen E, Hubner N, Petretto
E, Gauguier D, Kwitek A, et al: Genome Sequencing Reveals Loci under
Artificial Selection that Underlie Disease Phenotypes in the Laboratory
Rat. Cell 2013, 154:691–703.
14. Gilibert S, Kwitek AE, Hubner N, Tschannen M, Jacob HJ, Sassard J, Bataillard
A: Effects of chromosome 17 on features of the metabolic syndrome in
the Lyon hypertensive rat. Physiol Genomics 2008, 33:212–217.
15. Gilibert S, Bataillard A, Nussberger J, Sassard J, Kwitek AE: Implication of
chromosome 13 on hypertension and associated disorders in Lyon
hypertensive rats. J Hypertens 2009, 27:1186–1193.
16. Albrechtsen A, Nielsen FC, Nielsen R: Ascertainment biases in SNP chips
affect measures of population divergence. Mol Biol Evol 2010,
27:2534–2547.
17. Nielsen R, Signorovitch J: Correcting for ascertainment biases when
analyzing SNP data: applications to the estimation of linkage
disequilibrium. Theor Popul Biol 2003, 63:245–255.
18. Gibbs RA, Weinstock GM, Metzker ML, Muzny DM, Sodergren EJ, Scherer S,
Scott G, Steffen D, Worley KC, Burch PE, Okwuonu G, Hines S, Lewis L,
DeRamo C, Delgado O, Dugan-Rocha S, Miner G, Morgan M, Hawes A, Gill
R, Celera, Holt RA, Adams MD, Amanatides PG, Baden-Tillson H, Barnstead
M, Chin S, Evans CA, Ferriera S, Fosler C: Genome sequence of the Brown
Norway rat yields insights into mammalian evolution. Nature 2004,
428:493–521.19. Atanur SS, Birol I, Guryev V, Hirst M, Hummel O, Morrissey C, Behmoaras J,
Fernandez-Suarez XM, Johnson MD, McLaren WM, Patone G, Petretto E,
Plessy C, Rockland KS, Rockland C, Saar K, Zhao Y, Carninci P, Flicek P, Kurtz
T, Cuppen E, Pravenec M, Hubner N, Jones SJ, Birney E, Aitman TJ: The
genome sequence of the spontaneously hypertensive rat: Analysis and
functional significance. Genome Res 2010, 20:791–803.
20. Laulederkind SJ, Hayman GT, Wang SJ, Smith JR, Lowry TF, Nigam R, Petri V,
de Pons J, Dwinell MR, Shimoyama M, Munzenmaier DH, Worthey EA, Jacob
HJ: The Rat Genome Database 2013–data, tools and users. Brief Bioinform
2013, 14:520–526.
21. Kin T, Ono Y: Idiographica: a general-purpose web application to build
idiograms on-demand for human, mouse and rat. Bioinformatics
(Oxford, England) 2007, 23:2945–2946.
22. McLaren W, Pritchard B, Rios D, Chen Y, Flicek P, Cunningham F: Deriving
the consequences of genomic variants with the Ensembl API and SNP
Effect Predictor. Bioinformatics (Oxford, England) 2010, 26:2069–2070.
23. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P,
Kondrashov AS, Sunyaev SR: A method and server for predicting
damaging missense mutations. Nature methods 2010, 7:248–249.
24. Ugarte A, Eguibar JR, Cortes Mdel C, Leon-Chavez BA, Melo AI: Comparative
analysis of maternal care in the high-yawning (HY) and low-yawning (LY)
sublines from Sprague–Dawley rats. Dev Psychobiol 2011, 53:105–117.
25. Yen YC, Mauch CP, Dahlhoff M, Micale V, Bunck M, Sartori SB, Singewald N,
Landgraf R, Wotjak CT: Increased levels of conditioned fear and
avoidance behavior coincide with changes in phosphorylation of the
protein kinase B (AKT) within the amygdala in a mouse model of
extremes in trait anxiety. Neurobiol Learn Mem 2012, 98:56–65.
26. Bell R, Herring SM, Gokul N, Monita M, Grove ML, Boerwinkle E, Doris PA:
High-resolution identity by descent mapping uncovers the genetic basis
for blood pressure differences between spontaneously hypertensive rat
lines. Circ Cardiovasc Genet 2011, 4:223–231.
27. Wade CM, Kulbokas EJ 3rd, Kirby AW, Zody MC, Mullikin JC, Lander ES,
Lindblad-Toh K, Daly MJ: The mosaic structure of variation in the laboratory
mouse genome. Nature 2002, 420:574–578.
28. Adams DJ, Dermitzakis ET, Cox T, Smith J, Davies R, Banerjee R, Bonfield J,
Mullikin JC, Chung YJ, Rogers J, Bradley A: Complex haplotypes, copy
number polymorphisms and coding variation in two recently divergent
mouse strains. Nat Genet 2005, 37:532–536.
29. Watterson GA: On the number of segregating sites in genetical models
without recombination. Theor Popul Biol 1975, 7:256–276.
30. Reuveni E, Birney E, Gross CT: The consequence of natural selection on
genetic variation in the mouse. Genomics 2010, 95:196–202.
31. Wang L, Hao L, Li X, Hu S, Ge S, Yu J: SNP deserts of Asian cultivated rice:
genomic regions under domestication. J Evol Biol 2009, 22:751–761.
32. Subbaiyan GK, Waters DL, Katiyar SK, Sadananda AR, Vaddadi S, Henry RJ:
Genome-wide DNA polymorphisms in elite indica rice inbreds discovered
by whole-genome sequencing. Plant Biotechnol J 2012, 10:623–634.
33. Axelsson E, Ratnakumar A, Arendt ML, Maqbool K, Webster MT, Perloski M,
Liberg O, Arnemo JM, Hedhammar A, Lindblad-Toh K: The genomic signature
of dog domestication reveals adaptation to a starch-rich diet. Nature 2013,
495:360–364.
34. Kwitek-Black AE, Jacob HJ: The use of designer rats in the genetic
dissection of hypertension. Curr Hypertens Rep 2001, 3:12–18.
35. Corona G, Rastrelli G, Boddi V, Monami M, Melani C, Balzi D, Sforza A, Forti
G, Mannucci E, Maggi M: Prolactin levels independently predict major
cardiovascular events in patients with erectile dysfunction. Int J Androl
2011, 34:217–224.
36. Balbach L, Wallaschofski H, Volzke H, Nauck M, Dorr M, Haring R: Serum
prolactin concentrations as risk factor of metabolic syndrome or type 2
diabetes? BMC Endocr Disord 2013, 13:12.
37. Finlay C, Argoud K, Wilder SP, Ouali F, Ktorza A, Kaisaki PJ, Gauguier D:
Chromosomal mapping of pancreatic islet morphological features and
regulatory hormones in the spontaneously diabetic (Type 2) Goto-Kakizaki
rat. Mammalian genome : official journal of the International Mammalian
Genome Society 2010, 21:499–508.
38. Eberlein A, Kalbe C, Goldammer T, Brunner RM, Kuehn C, Weikard R:
Annotation of novel transcripts putatively relevant for bovine fat
metabolism. Mol Biol Rep 2011, 38:2975–2986.
39. Casas E, Shackelford SD, Keele JW, Koohmaraie M, Smith TP, Stone RT:
Detection of quantitative trait loci for growth and carcass composition
in cattle. J Anim Sci 2003, 81:2976–2983.
Ma et al. BMC Genomics 2014, 15:197 Page 14 of 14
http://www.biomedcentral.com/1471-2164/15/19740. De Camilli P, Thomas A, Cofiell R, Folli F, Lichte B, Piccolo G, Meinck HM,
Austoni M, Fassetta G, Bottazzo G, Bates D, Cartlidge N, Solimena M,
Kilimann MW: The synaptic vesicle-associated protein amphiphysin is the
128-kD autoantigen of Stiff-Man syndrome with breast cancer.
J Exp Med 1993, 178:2219–2223.
41. Fox CS, Heard-Costa N, Cupples LA, Dupuis J, Vasan RS, Atwood LD: Genome-wide
association to body mass index and waist circumference: the Framingham
Heart Study 100K project. BMC Med Genet 2007, 8(Suppl 1):S18.
42. Totsukawa G, Kaneko Y, Uchiyama K, Toh H, Tamura K, Kondo H: VCIP135
deubiquitinase and its binding protein, WAC, in p97ATPase-mediated
membrane fusion. Embo J 2011, 30:3581–3593.
43. Onichtchouk D, Chen YG, Dosch R, Gawantka V, Delius H, Massague J,
Niehrs C: Silencing of TGF-beta signalling by the pseudoreceptor BAMBI.
Nature 1999, 401:480–485.
44. Chen J, Bush JO, Ovitt CE, Lan Y, Jiang R: The TGF-beta pseudoreceptor
gene Bambi is dispensable for mouse embryonic development and
postnatal survival. Genesis 2007, 45:482–486.
45. Guillot N, Kollins D, Badimon JJ, Schlondorff D, Hutter R: Accelerated
reendothelialization, increased neovascularization and erythrocyte
extravasation after arterial injury in BAMBI−/− mice. PloS one 2013, 8:e58550.
46. Kamura T, Sato S, Iwai K, Czyzyk-Krzeska M, Conaway RC, Conaway JW: Activation
of HIF1alpha ubiquitination by a reconstituted von Hippel-Lindau (VHL)
tumor suppressor complex. Proc Natl Acad Sci USA 2000, 97:10430–10435.
47. Jiang C, Qu A, Matsubara T, Chanturiya T, Jou W, Gavrilova O, Shah YM,
Gonzalez FJ: Disruption of hypoxia-inducible factor 1 in adipocytes
improves insulin sensitivity and decreases adiposity in high-fat diet-fed
mice. Diabetes 2011, 60:2484–2495.
48. Boyden LM, Choi M, Choate KA, Nelson-Williams CJ, Farhi A, Toka HR, Tikhonova
IR, Bjornson R, Mane SM, Colussi G, Lebel M, Gordon RD, Semmekrot BA, Poujol
A, Valimaki MJ, De Ferrari ME, Sanjad SA, Gutkin M, Karet FE, Tucci JR, Stockigt JR,
Keppler-Noreuil KM, Porter CC, Anand SK, Whiteford ML, Davis ID, Dewar SB,
Bettinelli A, Fadrowski JJ, Belsha CW, et al: Mutations in kelch-like 3 and cullin 3
cause hypertension and electrolyte abnormalities. Nature 2012, 482:98–102.
49. Favre D, Le Gouill E, Fahmi D, Verdumo C, Chinetti-Gbaguidi G, Staels B,
Caiazzo R, Pattou F, Le KA, Tappy L, Regazzi R, Giusti V, Vollenweider P, Waeber
G, Abderrahmani A: Impaired expression of the inducible cAMP early repressor
accounts for sustained adipose CREB activity in obesity. Diabetes 2011,
60:3169–3174.
50. Muller FU, Lewin G, Matus M, Neumann J, Riemann B, Wistuba J, Schutz G,
Schmitz W: Impaired cardiac contraction and relaxation and decreased
expression of sarcoplasmic Ca2+−ATPase in mice lacking the CREM
gene. FASEB journal : official publication of the Federation of American
Societies for Experimental Biology 2003, 17:103–105.
51. Lewin G, Matus M, Basu A, Frebel K, Rohsbach SP, Safronenko A, Seidl MD,
Stumpel F, Buchwalow I, Konig S, Engelhardt S, Lohse MJ, Schmitz W, Muller
FU: Critical role of transcription factor cyclic AMP response element
modulator in beta1-adrenoceptor-mediated cardiac dysfunction.
Circulation 2009, 119:79–88.
52. Bhoj EJ, Romeo S, Baroni MG, Bartov G, Schultz RA, Zinn AR: MODY-like
diabetes associated with an apparently balanced translocation: possible
involvement of MPP7 gene and cell polarity in the pathogenesis of
diabetes. Mole Cytogenet 2009, 2:5.
53. Larson MG, Atwood LD, Benjamin EJ, Cupples LA, D'Agostino RB Sr, Fox CS,
Govindaraju DR, Guo CY, Heard-Costa NL, Hwang SJ, Murabito JM, Newton-Cheh
C, O'Donnell CJ, Seshadri S, Vasan RS, Wang TJ, Wolf PA, Levy D: Framingham
Heart Study 100K project: genome-wide associations for cardiovascular
disease outcomes. BMC Med Genet 2007, 8(Suppl 1):S5.
54. Meigs JB, Manning AK, Fox CS, Florez JC, Liu C, Cupples LA, Dupuis J:
Genome-wide association with diabetes-related traits in the Framingham
Heart Study. BMC Med Genet 2007, 8(Suppl 1):S16.
55. Vasan RS, Larson MG, Aragam J, Wang TJ, Mitchell GF, Kathiresan S, Newton-Cheh
C, Vita JA, Keyes MJ, O'Donnell CJ, Levy D, Benjamin EJ: Genome-wide association
of echocardiographic dimensions, brachial artery endothelial function and
treadmill exercise responses in the Framingham Heart Study. BMC Med Genet
2007, 8(Suppl 1):S2.
56. Ferrell F, Lanou A, Gray SD: Salt level in weaning diet affects saline
preference and fluid intake in Dahl rats. Hypertension 1986, 8:1021–1026.
57. Nishikimi T, Mori Y, Kobayashi N, Tadokoro K, Wang X, Akimoto K, Yoshihara
F, Kangawa K, Matsuoka H: Renoprotective effect of chronic adrenomedullin
infusion in Dahl salt-sensitive rats. Hypertension 2002, 39:1077–1082.58. Li H, Durbin R: Fast and accurate short read alignment with Burrows-
Wheeler transform. Bioinformatics (Oxford, England) 2009, 25:1754–1760.
59. McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A,
Garimella K, Altshuler D, Gabriel S, Daly M, DePristo MA: The Genome
Analysis Toolkit: a MapReduce framework for analyzing next-generation
DNA sequencing data. Genome Res 2010, 20:1297–1303.
60. DePristo MA, Banks E, Poplin R, Garimella KV, Maguire JR, Hartl C, Philippakis
AA, del Angel G, Rivas MA, Hanna M, McKenna A, Fennell TJ, Kernytsky AM,
Sivachenko AY, Cibulskis K, Gabriel SB, Altshuler D, Daly MJ: A framework
for variation discovery and genotyping using next-generation DNA
sequencing data. Nat Genet 2011, 43:491–498.
61. Quinlan AR, Hall IM: BEDTools: a flexible suite of utilities for comparing
genomic features. Bioinformatics (Oxford, England) 2010, 26:841–842.
62. Wand MP, Jones MC: Kernel Smoothing. Firstth edition. Chapman & Hall/CRC; 1995.
63. R Development Core Team: R: A Language and Environment for Statistical
Computing. Vienna, Austria: R Foundation for Statistical Computing; 2011.
64. Flicek P, Amode MR, Barrell D, Beal K, Brent S, Carvalho-Silva D, Clapham P,
Coates G, Fairley S, Fitzgerald S, Gil L, Gordon L, Hendrix M, Hourlier T,
Johnson N, Kahari AK, Keefe D, Keenan S, Kinsella R, Komorowska M,
Koscielny G, Kulesha E, Larsson P, Longden I, McLaren W, Muffato M,
Overduin B, Pignatelli M, Pritchard B, Riat HS, et al: Ensembl 2012.
Nucleic Acids Res 2012, 40:D84–90.
65. Kinsella RJ, Kähäri A, Haider S, Zamora J, Proctor G, Spudich G, Almeida-King
J, Staines D, Derwent P, Kerhornou A, Kersey P, Flicek P: Ensembl BioMarts:
a hub for data retrieval across taxonomic space. Database 2011:bar030.
doi:10.1093/database/bar030.
66. The UniProt Consortium: Reorganizing the protein space at the Universal
Protein Resource (UniProt). Nucleic Acids Res 2012, 40:D71–D75.
67. Ye J, Coulouris G, Zaretskaya I, Cutcutache I, Rozen S, Madden TL: Primer-BLAST:
a tool to design target-specific primers for polymerase chain reaction. BMC
Bioinformatics 2012, 13:134.
doi:10.1186/1471-2164-15-197
Cite this article as: Ma et al.: Genomic structure of nucleotide diversity
among Lyon rat models of metabolic syndrome. BMC Genomics
2014 15:197.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
